Ulf WIInberg - Dec 1, 2024 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Stock symbol
INKT
Transactions as of
Dec 1, 2024
Transactions value $
$14,947
Form type
4
Date filed
12/3/2024, 10:35 AM
Previous filing
Oct 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Award $14.9K +20.5K +16.55% $0.73 144K Dec 1, 2024 Direct F1
holding INKT Common Stock 278K Dec 1, 2024 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
F2 Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family.